Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Metagenomi (MGX) EBIT Margin (2023 - 2025)

Metagenomi (MGX) has disclosed EBIT Margin for 3 consecutive years, with 623.04% as the latest value for Q4 2025.

  • Quarterly EBIT Margin fell 40853.0% to 623.04% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 380.85% through Dec 2025, down 21085.0% year-over-year, with the annual reading at 380.85% for FY2025, 21085.0% down from the prior year.
  • EBIT Margin for Q4 2025 was 623.04% at Metagenomi, down from 263.76% in the prior quarter.
  • The five-year high for EBIT Margin was 84.28% in Q2 2024, with the low at 674.1% in Q1 2025.
  • Average EBIT Margin over 3 years is 272.54%, with a median of 210.86% recorded in 2023.
  • The sharpest move saw EBIT Margin surged 7416bps in 2024, then tumbled -41393bps in 2025.
  • Over 3 years, EBIT Margin stood at 162.88% in 2023, then tumbled by -32bps to 214.51% in 2024, then crashed by -190bps to 623.04% in 2025.
  • According to Business Quant data, EBIT Margin over the past three periods came in at 623.04%, 263.76%, and 246.53% for Q4 2025, Q3 2025, and Q2 2025 respectively.